➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
AstraZeneca
McKinsey
Moodys
Medtronic

Last Updated: April 12, 2021

DrugPatentWatch Database Preview

Strides Pharma Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has ninety-five approved drugs.

There are two tentative approvals on STRIDES PHARMA drugs.

Summary for Strides Pharma
US Patents:0
Tradenames:70
Ingredients:70
NDAs:95

Drugs and US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 090382-001 Oct 6, 2010 AB RX No No   Start Trial   Start Trial
Strides Pharma TENOFOVIR DISOPROXIL FUMARATE tenofovir disoproxil fumarate TABLET;ORAL 090742-001 Jan 26, 2018 AB RX No No   Start Trial   Start Trial
Strides Pharma PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET;ORAL 202702-005 Jun 3, 2014 AB RX No No   Start Trial   Start Trial
Strides Pharma RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 200536-001 Jun 28, 2011 DISCN No No   Start Trial   Start Trial
Strides Pharma CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 209226-001 Apr 30, 2018 AB RX No No   Start Trial   Start Trial
Strides Pharma RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 210010-001 Aug 1, 2018 DISCN No No   Start Trial   Start Trial
Strides Pharma MELOXICAM meloxicam TABLET;ORAL 077928-001 May 13, 2009 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.